secwatch / observer
8-K filed June 29, 2023, 7:59 PM ET ticker MBOT CIK 0000883975
other material confidence high sentiment neutral materiality 0.65

Microbot Medical raises $2M in registered direct offering; aggregate $7.6M from four offerings

Microbot Medical Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Microbot Medical Inc. entered into Securities Purchase Agreements with institutional investors valued at aggregate gross proceeds from the Offerings ... of approximately $2.0 million (effective 2023-06-26).

Action
entry
Agreement
equity purchase
Counterparty
institutional investors
Value
aggregate gross proceeds from the Offerings ... of approximately $2.0 million
Effective
2023-06-26
Exact text from the filing
On June 26, 2023, Microbot Medical Inc., a Delaware corporation (the “Company”), entered into Securities Purchase Agreements (the “Purchase Agreements”) with institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Registered Offering”), an aggregate of 624,618 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an offering price of $3.25 per share, for aggregate gross proceeds from the Offerings (as defined below) of approximately $2.0 million before deducting the placement agent fee (as described in greater detail below) and related offering expenses.
View on SEC.gov

26 material agreements filed in the last 30 days. Browse all material agreements →

Microbot Medical Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-022814
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.